Loading…

Reduced fibroblast growth factor 21 and β-Klotho secretion in untreated congenital isolated GH deficiency

Purposes Increasing evidence suggests that the FGF-Klotho endocrine system and the somatotropic system (pituitary and extra-pituitary GH) may have important metabolic and immune relationships, thus contributing to the pathophysiology of aging-related disorders, including diabetes, atherosclerosis, a...

Full description

Saved in:
Bibliographic Details
Published in:Endocrine 2021-07, Vol.73 (1), p.160-165
Main Authors: Oliveira-Santos, Alécia A., Salvatori, Roberto, Bueno, Ana C., Nogueira, Monica C., Campos, Viviane C., Melo, Manuela A., Oliveira, Carla R. P., Barros-Oliveira, Cynthia S., Marinho, Cindi G., Damascena, Nayra P., Santos, Elenilde G., Melo, Enaldo V., de Paula, Francisco J. A., de Castro, Margaret, Aguiar-Oliveira, Manuel H.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c375t-7a85fbed4a08b223b9cb7c0567a3fcb25cc8b3f14cf182754db1b635172519403
cites cdi_FETCH-LOGICAL-c375t-7a85fbed4a08b223b9cb7c0567a3fcb25cc8b3f14cf182754db1b635172519403
container_end_page 165
container_issue 1
container_start_page 160
container_title Endocrine
container_volume 73
creator Oliveira-Santos, Alécia A.
Salvatori, Roberto
Bueno, Ana C.
Nogueira, Monica C.
Campos, Viviane C.
Melo, Manuela A.
Oliveira, Carla R. P.
Barros-Oliveira, Cynthia S.
Marinho, Cindi G.
Damascena, Nayra P.
Santos, Elenilde G.
Melo, Enaldo V.
de Paula, Francisco J. A.
de Castro, Margaret
Aguiar-Oliveira, Manuel H.
description Purposes Increasing evidence suggests that the FGF-Klotho endocrine system and the somatotropic system (pituitary and extra-pituitary GH) may have important metabolic and immune relationships, thus contributing to the pathophysiology of aging-related disorders, including diabetes, atherosclerosis, and cancer. The status of these interactions in isolated GH deficiency (IGHD) is unknown. The objective of this study was to assess the response of both FGF21 and β-Klotho levels to a standard meal in a homogeneous group of adults with congenital untreated IGHD due to a homozygous mutation in the GHRH receptor gene. Methods In a cross-sectional study, we measured the levels of FGF21 and β-Klotho, before and 30, 60, 120, and 180 min after a standardized test meal in 20 (11 males) IGHD and 20 (11 males) age-matched controls. Areas under the curves (AUC) of FGF21 and β-Klotho were calculated. Results Baseline levels of FGF21 were similar, but baseline levels of β-Klotho were lower in IGHD subjects. The IGHD individuals exhibited lower AUC for FGF21 and β-Klotho levels than control subjects. There was a positive correlation between IGF1 and β-Klotho levels in the pooled groups. No correlation was found between IGF1 and FGF21 levels. Conclusions Subjects with lifetime, untreated IGHD exhibit reduced FGF21 and β-Klotho levels response to a mixed meal. This difference may have consequences on metabolism and aging.
doi_str_mv 10.1007/s12020-021-02700-6
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2506289909</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2542381472</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-7a85fbed4a08b223b9cb7c0567a3fcb25cc8b3f14cf182754db1b635172519403</originalsourceid><addsrcrecordid>eNp9kcFqFTEUhkNRbG19gS4k4MbN6MnJZDKzLEVbsSCIQnchySRtLnOTmmSQvpYP4jMZe9sKXbgICed85z_h_wk5ZvCOAcj3hSEgdICsHQnQDXvkgAkxddD6z9qbC9EBjJf75GUpGwBEHOQLss-5lMBHPCCbr25erZupDyYns-hS6VVOP-s19drWlCkyquNMf__qPi-pXidanM2uhhRpiHSNNTtdm4BN8crFUPVCQ0nLXe3snM7OBxtctLdH5LnXS3Gv7u9D8v3jh2-n593Fl7NPpycXneVS1E7qUXjj5l7DaBC5mayRFsQgNffWoLB2NNyz3no2ohT9bJgZuGASBZt64Ifk7U73JqcfqytVbUOxbll0dGktCgUMOE4TTA198wTdpDXH9rtG9chH1ktsFO4om1Mp2Xl1k8NW51vFQP1NQu2SUC0JdZeEGtrQ63vp1Wzd_DjyYH0D-A4ordWsy_92_0f2D7nRk-s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2542381472</pqid></control><display><type>article</type><title>Reduced fibroblast growth factor 21 and β-Klotho secretion in untreated congenital isolated GH deficiency</title><source>Springer Nature</source><creator>Oliveira-Santos, Alécia A. ; Salvatori, Roberto ; Bueno, Ana C. ; Nogueira, Monica C. ; Campos, Viviane C. ; Melo, Manuela A. ; Oliveira, Carla R. P. ; Barros-Oliveira, Cynthia S. ; Marinho, Cindi G. ; Damascena, Nayra P. ; Santos, Elenilde G. ; Melo, Enaldo V. ; de Paula, Francisco J. A. ; de Castro, Margaret ; Aguiar-Oliveira, Manuel H.</creator><creatorcontrib>Oliveira-Santos, Alécia A. ; Salvatori, Roberto ; Bueno, Ana C. ; Nogueira, Monica C. ; Campos, Viviane C. ; Melo, Manuela A. ; Oliveira, Carla R. P. ; Barros-Oliveira, Cynthia S. ; Marinho, Cindi G. ; Damascena, Nayra P. ; Santos, Elenilde G. ; Melo, Enaldo V. ; de Paula, Francisco J. A. ; de Castro, Margaret ; Aguiar-Oliveira, Manuel H.</creatorcontrib><description>Purposes Increasing evidence suggests that the FGF-Klotho endocrine system and the somatotropic system (pituitary and extra-pituitary GH) may have important metabolic and immune relationships, thus contributing to the pathophysiology of aging-related disorders, including diabetes, atherosclerosis, and cancer. The status of these interactions in isolated GH deficiency (IGHD) is unknown. The objective of this study was to assess the response of both FGF21 and β-Klotho levels to a standard meal in a homogeneous group of adults with congenital untreated IGHD due to a homozygous mutation in the GHRH receptor gene. Methods In a cross-sectional study, we measured the levels of FGF21 and β-Klotho, before and 30, 60, 120, and 180 min after a standardized test meal in 20 (11 males) IGHD and 20 (11 males) age-matched controls. Areas under the curves (AUC) of FGF21 and β-Klotho were calculated. Results Baseline levels of FGF21 were similar, but baseline levels of β-Klotho were lower in IGHD subjects. The IGHD individuals exhibited lower AUC for FGF21 and β-Klotho levels than control subjects. There was a positive correlation between IGF1 and β-Klotho levels in the pooled groups. No correlation was found between IGF1 and FGF21 levels. Conclusions Subjects with lifetime, untreated IGHD exhibit reduced FGF21 and β-Klotho levels response to a mixed meal. This difference may have consequences on metabolism and aging.</description><identifier>ISSN: 1355-008X</identifier><identifier>EISSN: 1559-0100</identifier><identifier>DOI: 10.1007/s12020-021-02700-6</identifier><identifier>PMID: 33770382</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adult ; Aging ; Arteriosclerosis ; Cross-Sectional Studies ; Diabetes ; Diabetes mellitus ; Dwarfism, Pituitary ; Endocrine system ; Endocrinology ; Fibroblast Growth Factors ; Growth hormone-releasing hormone ; Growth hormones ; Humanities and Social Sciences ; Humans ; Insulin-like growth factor I ; Internal Medicine ; Klotho protein ; Male ; Medicine ; Medicine &amp; Public Health ; multidisciplinary ; Original Article ; Pituitary ; Science</subject><ispartof>Endocrine, 2021-07, Vol.73 (1), p.160-165</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021</rights><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-7a85fbed4a08b223b9cb7c0567a3fcb25cc8b3f14cf182754db1b635172519403</citedby><cites>FETCH-LOGICAL-c375t-7a85fbed4a08b223b9cb7c0567a3fcb25cc8b3f14cf182754db1b635172519403</cites><orcidid>0000-0001-6495-2244</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33770382$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oliveira-Santos, Alécia A.</creatorcontrib><creatorcontrib>Salvatori, Roberto</creatorcontrib><creatorcontrib>Bueno, Ana C.</creatorcontrib><creatorcontrib>Nogueira, Monica C.</creatorcontrib><creatorcontrib>Campos, Viviane C.</creatorcontrib><creatorcontrib>Melo, Manuela A.</creatorcontrib><creatorcontrib>Oliveira, Carla R. P.</creatorcontrib><creatorcontrib>Barros-Oliveira, Cynthia S.</creatorcontrib><creatorcontrib>Marinho, Cindi G.</creatorcontrib><creatorcontrib>Damascena, Nayra P.</creatorcontrib><creatorcontrib>Santos, Elenilde G.</creatorcontrib><creatorcontrib>Melo, Enaldo V.</creatorcontrib><creatorcontrib>de Paula, Francisco J. A.</creatorcontrib><creatorcontrib>de Castro, Margaret</creatorcontrib><creatorcontrib>Aguiar-Oliveira, Manuel H.</creatorcontrib><title>Reduced fibroblast growth factor 21 and β-Klotho secretion in untreated congenital isolated GH deficiency</title><title>Endocrine</title><addtitle>Endocrine</addtitle><addtitle>Endocrine</addtitle><description>Purposes Increasing evidence suggests that the FGF-Klotho endocrine system and the somatotropic system (pituitary and extra-pituitary GH) may have important metabolic and immune relationships, thus contributing to the pathophysiology of aging-related disorders, including diabetes, atherosclerosis, and cancer. The status of these interactions in isolated GH deficiency (IGHD) is unknown. The objective of this study was to assess the response of both FGF21 and β-Klotho levels to a standard meal in a homogeneous group of adults with congenital untreated IGHD due to a homozygous mutation in the GHRH receptor gene. Methods In a cross-sectional study, we measured the levels of FGF21 and β-Klotho, before and 30, 60, 120, and 180 min after a standardized test meal in 20 (11 males) IGHD and 20 (11 males) age-matched controls. Areas under the curves (AUC) of FGF21 and β-Klotho were calculated. Results Baseline levels of FGF21 were similar, but baseline levels of β-Klotho were lower in IGHD subjects. The IGHD individuals exhibited lower AUC for FGF21 and β-Klotho levels than control subjects. There was a positive correlation between IGF1 and β-Klotho levels in the pooled groups. No correlation was found between IGF1 and FGF21 levels. Conclusions Subjects with lifetime, untreated IGHD exhibit reduced FGF21 and β-Klotho levels response to a mixed meal. This difference may have consequences on metabolism and aging.</description><subject>Adult</subject><subject>Aging</subject><subject>Arteriosclerosis</subject><subject>Cross-Sectional Studies</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Dwarfism, Pituitary</subject><subject>Endocrine system</subject><subject>Endocrinology</subject><subject>Fibroblast Growth Factors</subject><subject>Growth hormone-releasing hormone</subject><subject>Growth hormones</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Insulin-like growth factor I</subject><subject>Internal Medicine</subject><subject>Klotho protein</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>multidisciplinary</subject><subject>Original Article</subject><subject>Pituitary</subject><subject>Science</subject><issn>1355-008X</issn><issn>1559-0100</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kcFqFTEUhkNRbG19gS4k4MbN6MnJZDKzLEVbsSCIQnchySRtLnOTmmSQvpYP4jMZe9sKXbgICed85z_h_wk5ZvCOAcj3hSEgdICsHQnQDXvkgAkxddD6z9qbC9EBjJf75GUpGwBEHOQLss-5lMBHPCCbr25erZupDyYns-hS6VVOP-s19drWlCkyquNMf__qPi-pXidanM2uhhRpiHSNNTtdm4BN8crFUPVCQ0nLXe3snM7OBxtctLdH5LnXS3Gv7u9D8v3jh2-n593Fl7NPpycXneVS1E7qUXjj5l7DaBC5mayRFsQgNffWoLB2NNyz3no2ohT9bJgZuGASBZt64Ifk7U73JqcfqytVbUOxbll0dGktCgUMOE4TTA198wTdpDXH9rtG9chH1ktsFO4om1Mp2Xl1k8NW51vFQP1NQu2SUC0JdZeEGtrQ63vp1Wzd_DjyYH0D-A4ordWsy_92_0f2D7nRk-s</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Oliveira-Santos, Alécia A.</creator><creator>Salvatori, Roberto</creator><creator>Bueno, Ana C.</creator><creator>Nogueira, Monica C.</creator><creator>Campos, Viviane C.</creator><creator>Melo, Manuela A.</creator><creator>Oliveira, Carla R. P.</creator><creator>Barros-Oliveira, Cynthia S.</creator><creator>Marinho, Cindi G.</creator><creator>Damascena, Nayra P.</creator><creator>Santos, Elenilde G.</creator><creator>Melo, Enaldo V.</creator><creator>de Paula, Francisco J. A.</creator><creator>de Castro, Margaret</creator><creator>Aguiar-Oliveira, Manuel H.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6495-2244</orcidid></search><sort><creationdate>20210701</creationdate><title>Reduced fibroblast growth factor 21 and β-Klotho secretion in untreated congenital isolated GH deficiency</title><author>Oliveira-Santos, Alécia A. ; Salvatori, Roberto ; Bueno, Ana C. ; Nogueira, Monica C. ; Campos, Viviane C. ; Melo, Manuela A. ; Oliveira, Carla R. P. ; Barros-Oliveira, Cynthia S. ; Marinho, Cindi G. ; Damascena, Nayra P. ; Santos, Elenilde G. ; Melo, Enaldo V. ; de Paula, Francisco J. A. ; de Castro, Margaret ; Aguiar-Oliveira, Manuel H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-7a85fbed4a08b223b9cb7c0567a3fcb25cc8b3f14cf182754db1b635172519403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Aging</topic><topic>Arteriosclerosis</topic><topic>Cross-Sectional Studies</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Dwarfism, Pituitary</topic><topic>Endocrine system</topic><topic>Endocrinology</topic><topic>Fibroblast Growth Factors</topic><topic>Growth hormone-releasing hormone</topic><topic>Growth hormones</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Insulin-like growth factor I</topic><topic>Internal Medicine</topic><topic>Klotho protein</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>multidisciplinary</topic><topic>Original Article</topic><topic>Pituitary</topic><topic>Science</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oliveira-Santos, Alécia A.</creatorcontrib><creatorcontrib>Salvatori, Roberto</creatorcontrib><creatorcontrib>Bueno, Ana C.</creatorcontrib><creatorcontrib>Nogueira, Monica C.</creatorcontrib><creatorcontrib>Campos, Viviane C.</creatorcontrib><creatorcontrib>Melo, Manuela A.</creatorcontrib><creatorcontrib>Oliveira, Carla R. P.</creatorcontrib><creatorcontrib>Barros-Oliveira, Cynthia S.</creatorcontrib><creatorcontrib>Marinho, Cindi G.</creatorcontrib><creatorcontrib>Damascena, Nayra P.</creatorcontrib><creatorcontrib>Santos, Elenilde G.</creatorcontrib><creatorcontrib>Melo, Enaldo V.</creatorcontrib><creatorcontrib>de Paula, Francisco J. A.</creatorcontrib><creatorcontrib>de Castro, Margaret</creatorcontrib><creatorcontrib>Aguiar-Oliveira, Manuel H.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oliveira-Santos, Alécia A.</au><au>Salvatori, Roberto</au><au>Bueno, Ana C.</au><au>Nogueira, Monica C.</au><au>Campos, Viviane C.</au><au>Melo, Manuela A.</au><au>Oliveira, Carla R. P.</au><au>Barros-Oliveira, Cynthia S.</au><au>Marinho, Cindi G.</au><au>Damascena, Nayra P.</au><au>Santos, Elenilde G.</au><au>Melo, Enaldo V.</au><au>de Paula, Francisco J. A.</au><au>de Castro, Margaret</au><au>Aguiar-Oliveira, Manuel H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduced fibroblast growth factor 21 and β-Klotho secretion in untreated congenital isolated GH deficiency</atitle><jtitle>Endocrine</jtitle><stitle>Endocrine</stitle><addtitle>Endocrine</addtitle><date>2021-07-01</date><risdate>2021</risdate><volume>73</volume><issue>1</issue><spage>160</spage><epage>165</epage><pages>160-165</pages><issn>1355-008X</issn><eissn>1559-0100</eissn><abstract>Purposes Increasing evidence suggests that the FGF-Klotho endocrine system and the somatotropic system (pituitary and extra-pituitary GH) may have important metabolic and immune relationships, thus contributing to the pathophysiology of aging-related disorders, including diabetes, atherosclerosis, and cancer. The status of these interactions in isolated GH deficiency (IGHD) is unknown. The objective of this study was to assess the response of both FGF21 and β-Klotho levels to a standard meal in a homogeneous group of adults with congenital untreated IGHD due to a homozygous mutation in the GHRH receptor gene. Methods In a cross-sectional study, we measured the levels of FGF21 and β-Klotho, before and 30, 60, 120, and 180 min after a standardized test meal in 20 (11 males) IGHD and 20 (11 males) age-matched controls. Areas under the curves (AUC) of FGF21 and β-Klotho were calculated. Results Baseline levels of FGF21 were similar, but baseline levels of β-Klotho were lower in IGHD subjects. The IGHD individuals exhibited lower AUC for FGF21 and β-Klotho levels than control subjects. There was a positive correlation between IGF1 and β-Klotho levels in the pooled groups. No correlation was found between IGF1 and FGF21 levels. Conclusions Subjects with lifetime, untreated IGHD exhibit reduced FGF21 and β-Klotho levels response to a mixed meal. This difference may have consequences on metabolism and aging.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>33770382</pmid><doi>10.1007/s12020-021-02700-6</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-6495-2244</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1355-008X
ispartof Endocrine, 2021-07, Vol.73 (1), p.160-165
issn 1355-008X
1559-0100
language eng
recordid cdi_proquest_miscellaneous_2506289909
source Springer Nature
subjects Adult
Aging
Arteriosclerosis
Cross-Sectional Studies
Diabetes
Diabetes mellitus
Dwarfism, Pituitary
Endocrine system
Endocrinology
Fibroblast Growth Factors
Growth hormone-releasing hormone
Growth hormones
Humanities and Social Sciences
Humans
Insulin-like growth factor I
Internal Medicine
Klotho protein
Male
Medicine
Medicine & Public Health
multidisciplinary
Original Article
Pituitary
Science
title Reduced fibroblast growth factor 21 and β-Klotho secretion in untreated congenital isolated GH deficiency
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T14%3A19%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduced%20fibroblast%20growth%20factor%2021%20and%20%CE%B2-Klotho%20secretion%20in%20untreated%20congenital%20isolated%20GH%20deficiency&rft.jtitle=Endocrine&rft.au=Oliveira-Santos,%20Al%C3%A9cia%20A.&rft.date=2021-07-01&rft.volume=73&rft.issue=1&rft.spage=160&rft.epage=165&rft.pages=160-165&rft.issn=1355-008X&rft.eissn=1559-0100&rft_id=info:doi/10.1007/s12020-021-02700-6&rft_dat=%3Cproquest_cross%3E2542381472%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c375t-7a85fbed4a08b223b9cb7c0567a3fcb25cc8b3f14cf182754db1b635172519403%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2542381472&rft_id=info:pmid/33770382&rfr_iscdi=true